EMERGING DIABETES TRIAL RESULTS AND HOW THEY WILL SHAPE OUR MANAGEMENT STRATEGIES A Diabetes Breakthrough LI KA SHING KNOWLEDGE INSTITUTE 209 VICTORIA STREET, TORONTO M5B 1T8 SATURDAY DECEMBER 8 2018 FACULTY Lawrence A. Leiter, MD, FRCPC, FACP, FACE, FAHA, FACC Chair Endocrinologist, St. Michael’s Hospital Professor of Medicine and Nutritional Sciences, University of Toronto, Toronto, ON Subodh Verma, MD, PhD, FRCSC, FAHA Co-Chair Cardiac Surgeon, St. Michael’s Hospital Professor of Surgery and Pharmacology & Toxicology, University of Toronto, Canada Research Chair in Cardiovascular Surgery Toronto, ON Peter J. Lin, MD, CCFP Director, Primary Care Initiatives, Canadian Heart Research Centre Medical Director, LinCorp Medical Inc. Toronto, ON Ronald M. Goldenberg, MD, FRCPC, FACE Consultant Endocrinologist, North York General Hospital & LMC Diabetes & Endocrinology Vaughan, ON 7:45 am Breakfast and Registration 8:30 am Opening Remarks Dr. Lawrence A. Leiter 8:40 am Diabetes, CV Disease and the Rationale for the DECLARE-TIMI 58 Trial Dr. Subodh Verma 9:05 am Results from the DECLARE-TIMI 58 Trial Dr. Stephen D. Wiviott 9:35 am Results from a Meta-Analysis of the SGLT2i CVOTs Dr. Marc S. Sabatine 10:05 am Nutrition Break 10:35 am Clinical Implications of the DECLARE-TIMI 58 Trial Results Dr. Lawrence A. Leiter 10:55 am Q&A and Panel Discussion 11:45 am Translating the Evidence into Practice (Case-based presentations with key learnings for primary care practitioners and specialists) Drs. Subodh Verma, Ronald M. Goldenberg and Peter J. Lin 12:30 pm Closing Remarks Dr. Subodh Verma AGENDA Stephen D. Wiviott, MD, FACC Cardiologist, Brigham and Women’s Hospital Associate Professor of Medicine, Harvard Medical School Boston, MA Marc S. Sabatine, MD, MPH, FACC Chairman, TIMI Study Group Lewis Dexter, MD, Distinguished Chair in Cardiovascular Medicine, Brigham and Women’s Hospital Professor of Medicine, Harvard Medical School Boston, MA This program has received an educational grant from: AstraZeneca To register: www.ADiabetesBreakthrough.com • To review the relationship between diabetes and cardiovascular disease. • To summarise the findings from cardiovascular outcome trials in diabetes that have reported. • To discuss how to implement the clinical trial evidence into everyday practice to optimize diabetes management. LEARNING OBJECTIVES This Group Learning program has been certified by the College of Family Physicians of Canada and the Ontario Chapter for up to 3.50 Mainpro+ credits.